AI-generated summary
The authors conducted a systematic review and network meta-analysis of randomised trials comparing excimer 308-nm light combined with adjuvant treatments for vitiligo, including 38 studies involving 1841 participants. They report that combining excimer light with topical calcineurin inhibitors or topical corticosteroids improved repigmentation compared with excimer monotherapy, and that several other combinations were also associated with greater repigmentation. The abstract does not state these findings as certain, and the authors describe the results as highlighting combination therapy as a possible option.
- Participants
- 1,841
- Studies included
- 38
- Who or what was studied
- Patients with vitiligo treated with excimer 308-nm light, alone or combined with adjuvant therapies
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract does not describe the certainty of the evidence or the quality of the included trials, and comparisons rely on a network of indirect comparisons.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Meta-analysis, Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.